LED Medical Diagnostics Inc. Announces Appointment of Lamar Roberts as Vice President of Sales and Marketing
About VELscope® TechnologyAccording to the Oral Cancer Foundation, nearly 42,000 Americans will be diagnosed with oral or pharyngeal cancer this year. However, that is just over 8 percent of the approximately 640,000 people diagnosed annually on a worldwide basis. LED Medical's product, the VELscope® VX Enhanced Oral Assessment System, is changing the way dental practitioners examine the oral mucosa and screen for tissue abnormalities. The VELscope® Vx allows a wide variety of oral abnormalities to be detected ? often before they're visible to the unassisted eye. The VELscope Vx® is further intended to be used by surgeons as a tool to assist in identifying diseased tissue around a clinically apparent lesion and thus aid in determining the appropriate margin for surgical excision.
About LED Medical Diagnostics Inc.Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED Medical Diagnostics Inc. is a leading developer of LED?based visualization technologies for the medical industry. The Company is currently listed on the Toronto Stock Exchange (TSX?V) under the symbol "LMD", the OTCQX under the symbol "LEDIF", as well as the Frankfurt Stock Exchange under the symbol "LME". For more information, visit www.ledmd.com. Through its wholly?owned subsidiary, LED Dental Inc., the company manufactures the VELscope® Vx Enhanced Oral Assessment System, the first system in the world to apply tissue fluorescence visualization technology to the oral cavity. VELscope® Vx devices are now used to conduct more screenings for oral cancer and other oral diseases than any other adjunctive device. To date, there have been more than 12,000 VELscope® Vx systems sold globally and they have been used to perform more than 25 million exams. For more information, call 604.434.4614 or visit www.leddental.com.
For media or investor relations inquiries, please contact:
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.